| T6S1676 |
Cimigenoside
|
27994-11-2
|
|
|
|
Cimigenoside is a triterpenoid glycoside from the genus Cimicifuga.
|
| T7190 |
Actein
|
18642-44-9
|
|
|
|
Actein has a stimulatory effect on osteoblastic bone formation or has potential activity against osteoporosis, it also can prevent oxidative damage to osteoblast...
|
| TN1222 |
26-Deoxyactein
|
264624-38-6
|
98.06%
|
|
|
23-epi-26-Deoxyactein (27-Deoxyactein) has anti-inflammatory activity, it inhibits nitric oxide production by reducing iNOS expression without affecting activity...
|
| T3805 |
Prim-O-glucosylcimifugin
|
80681-45-4
|
99.54%
|
|
|
Prim-O-glucosylcimifugin (Cimifugin 7-glucoside) can inhibit the proliferation of SMC(smooth muscle cell) stimulated by TNF-alpha, increase the proportion of G0/...
|
| T5S1679 |
Acetylshengmanol Arabinoside
|
402513-88-6
|
99.62%
|
|
|
Acetylcimigenol 3-O-alpha-L-arabinopyranoside is an extract derived from Cimicifuga.
|
| T5S1677 |
Cimiracemoside D
|
290821-39-5
|
99.66%
|
|
|
Cimiracemoside D is a natural product from Cimicifuga foetida L.
|
| TN1499 |
Cimiracemoside C
|
256925-92-5
|
99.73%
|
|
|
Cimiracemoside C (Cimicifugoside M) is an active component of Cimicifuga racemosa. It activates AMPK and has the potential activity against diabetes.
|
| T5087 |
DL-Isocitric acid trisodium salt
|
1637-73-6
|
99.79%
|
|
|
DL-Isocitric acid trisodium salt is the protonated form of isocitrate, a substrate in the citric acid cycle. DL-Isocitric acid trisodium salt is useful as a mark...
|
| T3383 |
Cimifugin
|
37921-38-3
|
99.87%
|
|
|
Cimifugin (Cimitin) inhibits NO production induced by lipopolysaccharide in macrophage cell line RAW 264.7 and for 1, 1-diphenyl-2-picrylhydrazyl free-radical sc...
|
| TN1494 |
Cimicifugoside H-1
|
163046-73-9
|
99.91%
|
|
|
Cimicifugoside H1 shows the protective function to cerebral neuron during cerebral ischemia.
|
| TN3655 |
Cimiside E
|
154822-57-8
|
98%
|
|
|
Cimiside E has anti-inflammatory activity, it selectively inhibits TNF-α-induced expression of VCAM-1 at least by upregulation of PPAR-γ, and signals for ERK1/2,...
|
| TN3653 |
Cimidahurinine
|
142542-89-0
|
98%
|
|
|
Cimidahurinine can attenuate Doxorubicin (DOX)-induced cardiotoxicity in a dose-dependent manner with EC50 values of 45.79 uM; it protects against cardiotoxicity...
|
| TN1498 |
Cimigenol
|
3779-59-7
|
98%
|
|
|
Cimigenol is a potential antitumor compound, combination of it with an autophagy inhibitor may be a valuable strategy for the chemoprevention or treatment of col...
|
| TN1495 |
Cimicifugoside H2
|
161097-77-4
|
98%
|
|
|
Cimicifugoside H2 is a natural product from Cimicifuga foetida.
|
| TN3652 |
Cimicifugic acid B
|
205114-66-5
|
98%
|
|
|
Cimicifugic acid B is a natural product for research related to life sciences. The catalog number is TN3652 and the CAS number is 205114-66-5.
|
| TN4669 |
Norkhellol
|
4439-68-3
|
98%
|
|
|
Norkhellol is a natural product for research related to life sciences. The catalog number is TN4669 and the CAS number is 4439-68-3.
|
| TN1497 |
Cimigenol-3-one
|
31222-32-9
|
98%
|
|
|
Cimigenol-3-one is a natural product from Calophyllum inophyllum.
|
| TN2825 |
25-Anhydrocimigenol 3-O-beta-D-xyloside
|
181765-11-7
|
98%
|
|
|
25-Anhydrocimigenol 3-O-beta-D-xyloside has notable cytotoxicity against HepG2 and MCF-7 cancer cell lines.
|
| TN3219 |
7,8-Didehydrocimigenol
|
150972-72-8
|
98%
|
|
|
7,8-Didehydrocimigenol can be used for the treatment of cardiovascular disorders such as atherosclerosis. It upregulates PPAR-γ in EC inhibits NF-kB activity of ...
|
| TN1229 |
26-Deoxycimicifugoside
|
214146-75-5
|
98%
|
|
|
26-Deoxycimicifugoside is a natural product from Cimicifuga foetida L.
|
